LGP
vs
S
S&P/ASX 300
LGP
Over the past 12 months, LGP has underperformed S&P/ASX 300, delivering a return of -8% compared to the S&P/ASX 300's +4% growth.
Stocks Performance
LGP vs S&P/ASX 300
Performance Gap
LGP vs S&P/ASX 300
Performance By Year
LGP vs S&P/ASX 300
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Little Green Pharma Ltd
Glance View
Little Green Pharma Ltd. produces medicinal cannabis products for sale to Australian patients. The company is headquartered in Perth, Western Australia. The company went IPO on 2020-02-20. The Company’s products includes LGP Classic range and LGP Flower range. Its LGP Classic range includes tetrahydrocannabinol (THC) and cannabidiol (CBD) ratios presented in an oil formulation. Its LGP Flower range is grown and manufactured in the Southwest of Western Australia and supplied as dried medicinal cannabis whole flowers. The firm supplies medical-grade cannabis products to Australian, European and overseas markets. The company is also engaged in promoting education and outreach programs.
